drugset / Trial / NCT05563610

Oral Penicillin Challenge and Allergy De-labeling in Children

NCT05563610 ↗

Phase 4 Terminated 31 enrolled Phoenix Children's Hospital
RandomizedParallel-groupOpen-labelDiagnostic

Summary

The primary purpose of this study is to investigate the portion of penicillin allergy labels that are not true allergies using oral amoxicillin challenges among pediatric patients. The secondary purpose is to evaluate the safety and feasibility of administering oral penicillin allergy challenges in the Pediatric Emergency Department.

Timeline

Start
2022-09-26
Primary completion
2024-06-12
Completion
2024-06-12

Outcome

Outcome not reported

Stopped (Enrollment): “Unable to recruit sufficient number of subjects in the setting”

Drugs

EvaluationDrugModalityDoseRoute
Subject Amoxicillin Other / unclassified 500 mg Oral